A simple, time- and cost-effective, high-throughput depletion strategy for deep plasma proteomics.


Journal

Science advances
ISSN: 2375-2548
Titre abrégé: Sci Adv
Pays: United States
ID NLM: 101653440

Informations de publication

Date de publication:
29 03 2023
Historique:
medline: 31 3 2023
entrez: 29 3 2023
pubmed: 30 3 2023
Statut: ppublish

Résumé

We introduce a cost-effective, robust high-throughput-compatible plasma depletion method enabling in-depth profiling of plasma that detects >1300 proteins per run with a throughput of 60 samples per day. The method has been fully validated by processing >3000 samples with no apparent batch effect at a cost for the depletion step of ~$2.5 per sample.

Identifiants

pubmed: 36989362
doi: 10.1126/sciadv.adf9717
pmc: PMC10058233
doi:

Substances chimiques

Proteins 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

eadf9717

Références

Mol Cell Proteomics. 2002 Nov;1(11):845-67
pubmed: 12488461
J Mol Med (Berl). 2019 Oct;97(10):1451-1463
pubmed: 31385015
EBioMedicine. 2022 Sep;83:104208
pubmed: 35952496
Clin Chem. 2010 Feb;56(2):177-85
pubmed: 19884488
J Clin Invest. 1948 Sep;27(5):609-16
pubmed: 16695579
J Proteome Res. 2022 Nov 4;21(11):2810-2814
pubmed: 36201825
Nucleic Acids Res. 2014 Jan;42(Database issue):D959-65
pubmed: 24304897
Nat Methods. 2020 Jan;17(1):41-44
pubmed: 31768060
Science. 2020 Sep 4;369(6508):1210-1220
pubmed: 32788292
Cell. 2022 Mar 3;185(5):916-938.e58
pubmed: 35216673
Nat Methods. 2020 Sep;17(9):869-870
pubmed: 32669682
Nat Methods. 2017 May;14(5):513-520
pubmed: 28394336
Proteomics. 2005 Aug;5(13):3531-6
pubmed: 16041672
Sci Adv. 2021 Nov 26;7(48):eabj5629
pubmed: 34826237
Mol Cell Proteomics. 2021;20:100077
pubmed: 33813065
J Proteome Res. 2006 Apr;5(4):925-34
pubmed: 16602700
Cell Syst. 2020 Jul 22;11(1):11-24.e4
pubmed: 32619549
mBio. 2022 Jun 28;13(3):e0056722
pubmed: 35446128
Sci Immunol. 2021 Aug 10;6(62):
pubmed: 34376480

Auteurs

Arthur Viode (A)

Department of Pathology, Boston Children's Hospital, Boston, MA, USA.
Harvard Medical School, Boston, MA, USA.

Patrick van Zalm (P)

Department of Pathology, Boston Children's Hospital, Boston, MA, USA.
Harvard Medical School, Boston, MA, USA.
Department of Neuropsychology and Psychopharmacology, EURON, Faculty of Psychology and Neuroscience, Maastricht University, Maastricht, Netherlands.

Kinga K Smolen (KK)

Harvard Medical School, Boston, MA, USA.
Precision Vaccines Program, Division of Infectious Diseases, Boston Children's Hospital, Boston, MA, USA.

Benoit Fatou (B)

Department of Pathology, Boston Children's Hospital, Boston, MA, USA.
Harvard Medical School, Boston, MA, USA.

David Stevenson (D)

Department of Pathology, Boston Children's Hospital, Boston, MA, USA.

Meenakshi Jha (M)

Department of Pathology, Boston Children's Hospital, Boston, MA, USA.

Ofer Levy (O)

Harvard Medical School, Boston, MA, USA.
Precision Vaccines Program, Division of Infectious Diseases, Boston Children's Hospital, Boston, MA, USA.
Broad Institute of MIT and Harvard, Cambridge, MA, USA.

Judith Steen (J)

Department of Neuropsychology and Psychopharmacology, EURON, Faculty of Psychology and Neuroscience, Maastricht University, Maastricht, Netherlands.
F. M. Kirby Neurobiology Center, Boston Children's Hospital, Boston, MA, USA.

Hanno Steen (H)

Department of Pathology, Boston Children's Hospital, Boston, MA, USA.
Harvard Medical School, Boston, MA, USA.
Precision Vaccines Program, Division of Infectious Diseases, Boston Children's Hospital, Boston, MA, USA.

Articles similaires

Databases, Protein Protein Domains Protein Folding Proteins Deep Learning
Humans Cost-Benefit Analysis Brain Neoplasms Male Female
Humans Arthritis, Rheumatoid Lipid Metabolism Male Female

Classifications MeSH